Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fischer Medical Ventures Limited has announced the closure of its trading window from Saturday, March 21, 2026, until 48 hours after the board meeting scheduled for Tuesday, March 24, 2026. The closure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015, and applies to promoters, directors, designated persons, and their immediate relatives. The upcoming board meeting will consider the appointment of a Company Secretary and Compliance Officer. The company is formerly known as Fischer Chemic Limited, based in Visakhapatnam, with a corporate office in Chennai.
This is a routine regulatory compliance filing and is not expected to have a material impact on the stock price. The board meeting agenda is administrative in nature, focused on appointing a Company Secretary and Compliance Officer, rather than any major corporate action.